Updated: Ultragenyx to lay off about 130 employees, resubmit rare disease application again

Ultragenyx announced Thursday afternoon that the FDA would not take up its recent gene therapy application. Additionally, it will lay off about 10% of its employees as part of a restructuring, following a bumpy 2025 ...